HashiCorp Inc (NASDAQ: HCP) is 12.10% higher on its value in year-to-date trading and has touched a low of $18.91 and a high of $36.39 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HCP stock was last observed hovering at around $25.74 in the last trading session, with the day’s gains setting it 0.76%.
Currently trading at $26.50, the stock is 5.86% and 12.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.87 million and changing 2.95% at the moment leaves the stock 6.97% off its SMA200. HCP registered -10.74% loss for a year compared to 6-month loss of 5.28%. The firm has a 50-day simple moving average (SMA 50) of $7.18 and a 200-day simple moving average (SMA200) of -$15.49.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.41% gain in the last 1 month and extending the period to 3 months gives it a 21.90%, and is -0.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.40% over the week and 4.77% over the month.
HashiCorp Inc (HCP) has around 2400 employees, a market worth around $5.28B and $583.14M in sales. Fwd P/E is 99.59. Profit margin for the company is -32.70%. Distance from 52-week low is 40.14% and -27.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.59%).
HashiCorp Inc quarterly earnings per share for the current quarter are estimated at -$0.01 with sales reaching $153.14M over the same period.The EPS is expected to grow by 182.91% this year, but quarterly earnings will post 10.70% year-over-year.
HashiCorp Inc (HCP) Top Institutional Holders
323 institutions hold shares in HashiCorp Inc (HCP), with institutional investors hold 88.53% of the company’s shares. The shares outstanding are 125.33M, and float is at 111.29M with Short Float at 6.65%. Institutions hold 84.22% of the Float.
The top institutional shareholder in the company is JP Morgan Chase & Company with over 11.16 million shares valued at $292.21 million. The investor’s holdings represent 10.20% of the HCP Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 9.27 million shares valued at $242.63 million to account for 8.47% of the shares outstanding. The other top investors are Baillie Gifford and Company which holds 7.39 million shares representing 6.76% and valued at over $193.44 million, while Blackrock Inc. holds 4.05% of the shares totaling 4.43 million with a market value of $115.89 million.
HashiCorp Inc (HCP) Insider Activity
The most recent transaction is an insider sale by Holmes Marc,the company’sCHIEF MARKETING OFFICER. SEC filings show that Holmes Marc sold 13,916 shares of the company’s common stock on Mar 11 ’24 at a price of $26.19 per share for a total of $0.36 million. Following the sale, the insider now owns 0.0 shares.
HashiCorp Inc disclosed in a document filed with the SEC on Mar 04 ’24 that Dadgar Armon (CHIEF TECHNOLOGY OFFICER) sold a total of 35,904 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $25.45 per share for $0.91 million. Following the transaction, the insider now directly holds 1.73 million shares of the HCP stock.
Still, SEC filings show that on Feb 26 ’24, Welihinda Navam (CHIEF FINANCIAL OFFICER) disposed off 2,500 shares at an average price of $25.00 for $62500.0. The insider now directly holds 62,844 shares of HashiCorp Inc (HCP).
